Heart Transplant
Definition
A heart transplant is a surgical procedure in which a diseased or failing heart is replaced with a healthy donor heart. It is typically performed as a last resort for patients with end-stage heart failure or severe coronary artery disease when other treatments have been unsuccessful.
Related Specialists
Showing 3 of 173
Related Fact Sheets
Showing 6 of 8
Related News
Showing 3 of 5
Related Departments
Showing 3 of 4
General Heart Failure Program
Our highly skilled cardiologists expertly treat and diagnose heart failure—a chronic, progressive condition in which the heart muscle can’t pump enough blood to meet the body's needs. In addition to caring for cardiac patients at Yale New Haven Hospital, we provide treatment to the rapidly growing number of outpatients living with heart failure in the community. We treat each patient with a personalized plan, carefully monitoring medications on an ongoing basis while minding other issues that affect cardiac health. We also educate patients and their families about lifestyle changes, prescribe and oversee exercise rehabilitation programs, and facilitate communication between the many professionals involved in outpatient care. Our physicians work as part of a multidisciplinary team to offer patients comprehensive care with the goal of prolonging their life and improving its quality. Treatment options may include medications, short- or long-term mechanical support, or heart transplant. Before treatment begins, we perform cardiac diagnostic procedures, such as stress tests, catheterization, and biopsies. We collaborate with cardiac-trained radiologists to provide noninvasive imaging studies including positron emission tomography (PET), computed tomography (CT), magnetic resonance imaging (MRI), and 2D and 3D electrocardiography. At the Center for Advanced Heart Failure at Yale New Haven Hospital, we treat the full continuum of heart failure and offer a variety of medical and surgical treatment options. The center cares for patients with an LVAD (left ventricular assist device), a battery-operated mechanical pump that is surgically implanted and helps maintain the heart’s pumping ability when it can’t work effectively on its own. This is the only long-term mechanical circulatory support for patients otherwise ineligible for heart transplant. Our surgeons regularly perform heart transplants and LVAD implantations, and our heart transplant survival and post-LVAD rates are among the best in the region.Advanced Heart Failure Program
The Advanced Heart failure Program is a rapidly expanding service at the front lines of treating heart failure. Launched in 1988, the program builds upon decades of experience treating failing hearts. In 2019, we performed 49 heart transplants, putting us among the top centers of the country. Our left ventricular assist device program treats more cases than any other program in the Northeast. It provides heart pumps for patients who need support while they are waiting for a donor heart or who are ineligible for a transplant and need another permanent solution. Heart transplants are the gold standard treatment for patients with end-stage heart failure. But many face a long, difficult wait for a donor heart, and some don’t survive. Yale Medicine is one of a handful of centers in the country to push existing boundaries in heart transplant by aggressively seeking out donor hearts other centers turn down even though they may be suitable for some patients. This process, using what’s called “donation after circulatory death” (DCD) organs, is helping more of our patients get heart transplants sooner. What’s more, our one-year survival rates for heart transplants—93%—are better than the national average. Multi-organ transplants People who live with heart failure have a high likelihood of also having kidney dysfunction from a variety of causes, and this can be a limiting factor in being able to get a heart transplant. For these patients, our heart specialists collaborate with Yale Medicine’s world-class abdominal transplant team and have achieved a robust volume and successful track record in performing heart-kidney transplants. Pioneers in LVAD Yale Medicine helped to pioneer the use of left ventricular assist devices (LVADs), providing patients whose hearts are too weak to function on their own with implantable devices that can pump blood for them. Yale Medicine is one of the leaders in the Northeast in volume and outcomes with LVADs and is certified by the Joint Commission, the nation’s predominant standard-setting and accrediting body in health care. Each one of our patients is treated by a team that includes cardiologists, transplant surgeons, infectious disease specialists, nephrologists, critical care doctors, nurses, pharmacists, social workers, nutritionists, and transplant coordinators, among others. Transplant doctors at Yale are national leaders in the field. Currently, the presidents of United Network for Organ Sharing (UNOS) and the American Society of Transplantation are at Yale, and they have helped to write the guidelines for how to treat patients after solid organ transplants as the field advances. Outcomes above average Patients whose future once seemed difficult have survived for decades after a heart transplant or LVAD implant. The average one-year survival after a Yale Medicine heart transplant is 93%, which is higher than the national average. This is partly due to meticulous follow-up care that includes treatment with immunosuCardiac Surgery
Yale Medicine Cardiac Surgery is a team of world-class heart surgeons, devoted exclusively to the cardiac care of adults and children. Our surgeons perform state-of-the-art minimally invasive and traditional operations for the full range of cardiac diseases and conditions, including: Coronary artery bypass grafting (CABG) Valve repair and replacement (aortic and mitral) Aneurysm repair (aortic, thoracic aortic, left ventricular) Arrhythmia (abnormal heart rhythm), including hybrid ablation heart failure and artificial heart or ventricular assist devices Heart failure, including artificial heart or ventricular assist devices Heart transplantation Congenital heart diseases in children and adults Our cardiac surgery team provides personalized, compassionate care for adult and pediatric patients. We understand that living with cardiac conditions comes with challenges. We will partner with patients and their families to explore treatment options, as well as strategies that can assist them after surgery. Our cardiac surgery teamincludes some of the most experienced cardiac surgeonsin the world, as well as a dedicated team of experienced cardiologists, cardiac nurses, physician assistants, and nurse practitioners. We also collaborate with leading cardiologists at Yale in the treatment of heart failure, coronary artery disease, valve disease, and arrhythmias. Yale's survival statistics for coronary artery bypass, mitral valve replacement, and aortic valve replacement consistently exceed national and regional averages, with Yale performing the most mitral valve operations in the state, as well as caring for the largest volume of aortic cases statewide. We also have experience with robot-assisted cardiac surgery, minimally invasive valve repair and replacement, and surgical ablation for atrial fibrillation. Our surgeons operate at Yale New Haven Hospital, Bridgeport Hospital, and the Veterans Affairs (VA) Connecticut Healthcare System in West Haven, where they work closely with internists, cardiologists, and vascular surgeons in pre- and post-operative care. As faculty in the Yale School of Medicine Department of Surgery,our surgeonsconduct groundbreaking research in aortic surgery, transplantation, experimental mechanical heart and cardiac transplantation, and vascular biology.